These findings corroborate the CRHR2 downregulation and Ucn2 elevation observed in vivo in TNBS-induced colitis animal models and ex vivo in UC human biopsies, in the late stages of inflammation [9,94,101]. The gene discussed is CRHR2; the disease is colitis.